Key Takeaways OGN received FDA approval extending NEXPLANON's contraceptive use from three years to up to five years.Trial data show no pregnancies in years four and five, showing efficacy across a wide range of BMIs.The approval introduces a new REMS program to certify providers for proper insertion and removal.Organon & Co. (OGN) recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...